Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Sunvozertinib for patients in China with platinum-pretreated locally advanced or metastatic non-small-cell lung cancer and EGFR exon 20 insertion mutation (WU-KONG6): single-arm, open-label, multicentre, phase 2 trial

PaperCitations, authors & open-access status

Sunvozertinib for patients in China with platinum-pretreated locally advanced or metastatic non-small-cell lung cancer and EGFR exon 20 insertion mutation (WU-KONG6): single-arm, open-label, multicentre, phase 2 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 68 citations, 2023 year and closed oa status.

68
Citations
2023
Year
closed
OA Status

Related on ScholarIQ

Lin Wang
Author
Ying Hu
Author
The Lancet Respiratory Medicine
Journal
Lung Cancer Treatments and Mutations
Topic
Lung Cancer Treatments and Mutations
Topic
Lung Cancer Research Studies
Topic
470M+ articles · free account